Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [Internet]. 27. Februar 2025 [zitiert 24. August 2026];3(1). Verfügbar unter: https://shmpublisher.com/index.php/johmpe/article/view/547